Secondary Logo

Most Popular Articles

Single-Dose Pharmacokinetics and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson Disease: A Comparison With Immediate-Release Carbidopa-Levodopa and With Extended-Release Carbidopa-Levodopa Capsules

Modi, Nishit B.; Mittur, Aravind; Rubens, Robert; More

Clinical Neuropharmacology. 42(1):4-8, January/February 2019.

Baclofen in the Therapeutic of Sequele of Traumatic Brain Injury: Spasticity

Pérez-Arredondo, Adán; Cázares-Ramírez, Eduardo; Carrillo-Mora, Paul; More

Clinical Neuropharmacology. 39(6):311-319, November/December 2016.

Long-term Outcome of Adenosine A2A Receptor Antagonist on Lower Urinary Tract Symptoms in Male Parkinson Disease Patients

Kitta, Takeya; Yabe, Ichiro; Kanno, Yukiko; More

Clinical Neuropharmacology. 41(3):98-102, May/June 2018.

Effect of Concomitant Medications on the Safety and Efficacy of Extended-Release Carbidopa-Levodopa (IPX066) in Patients With Advanced Parkinson Disease: A Post Hoc Analysis

LeWitt, Peter A.; Verhagen Metman, Leo; Rubens, Robert; More

Clinical Neuropharmacology. 41(2):47-55, March/April 2018.

Comparing the Effects of Atorvastatin With Sodium Valproate (Divalproex) on Frequency and Intensity of Frequent Migraine Headaches: A Double-blind Randomized Controlled Study

Hesami, Omid; Sistanizad, Mohammad; Asadollahzade, Elnaz; More

Clinical Neuropharmacology. 41(3):94-97, May/June 2018.

Clostridium butyricum MIYAIRI 588 as Adjunctive Therapy for Treatment-Resistant Major Depressive Disorder: A Prospective Open-Label Trial

Miyaoka, Tsuyoshi; Kanayama, Misako; Wake, Rei; More

Clinical Neuropharmacology. 41(5):151-155, September/October 2018.

Show: